Viemed Healthcare (VMD) EBITDA Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -529.00 |
| Dec 31, 2025 | 314.00 |
| Sep 30, 2025 | -23.00 |
| Jun 30, 2025 | 158.00 |
| Mar 31, 2025 | -413.00 |
| Dec 31, 2024 | 93.00 |
| Sep 30, 2024 | 312.00 |
| Jun 30, 2024 | 341.00 |
| Mar 31, 2024 | -368.00 |
| Dec 31, 2023 | 94.00 |
| Sep 30, 2023 | 53.00 |
| Jun 30, 2023 | 154.00 |
| Mar 31, 2023 | -252.00 |
| Dec 31, 2022 | 309.00 |
| Sep 30, 2022 | 18.00 |
| Jun 30, 2022 | -289.00 |
| Mar 31, 2022 | -698.00 |
| Dec 31, 2021 | 677.00 |
| Sep 30, 2021 | 49.00 |
| Jun 30, 2021 | -61.00 |
| Mar 31, 2021 | -1,004.00 |
| Dec 31, 2020 | 788.00 |
| Sep 30, 2020 | -3,677.00 |
| Jun 30, 2020 | 2,871.00 |
| Mar 31, 2020 | 501.00 |
| Dec 31, 2019 | -207.00 |
| Sep 30, 2019 | 778.00 |
| Jun 30, 2019 | -501.00 |
| Mar 31, 2019 | -214.00 |
| Dec 31, 2018 | -137.00 |
| Sep 30, 2018 | -124.00 |
| Jun 30, 2018 | -269.00 |